Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.
De Vivo, I
Al Olama, AA
Breast Cancer Association Consortium (BCAC),
Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON),
Colon Cancer Family Registry (CCFR),
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT),
Endometrial Cancer Association Consortium (ECAC),
Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO),
Melanoma Genetics Consortium (GenoMEL),
Glioma International Case-Control Study (GICC),
International Lung Cancer Consortium (ILCCO),
Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium,
International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph),
Ovarian Cancer Association Consortium (OCAC),
Oral Cancer GWAS,
Pancreatic Cancer Case-Control Consortium (PanC4),
Pancreatic Cancer Cohort Consortium (PanScan),
Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL),
Renal Cancer GWAS,
Testicular Cancer Consortium (TECAC),
MetadataShow full item record
Genome-wide association studies (GWAS) have led to the identification of hundreds of susceptibility loci across cancers, but the impact of further studies remains uncertain. Here we analyse summary-level data from GWAS of European ancestry across fourteen cancer sites to estimate the number of common susceptibility variants (polygenicity) and underlying effect-size distribution. All cancers show a high degree of polygenicity, involving at a minimum of thousands of loci. We project that sample sizes required to explain 80% of GWAS heritability vary from 60,000 cases for testicular to over 1,000,000 cases for lung cancer. The maximum relative risk achievable for subjects at the 99th risk percentile of underlying polygenic risk scores (PRS), compared to average risk, ranges from 12 for testicular to 2.5 for ovarian cancer. We show that PRS have potential for risk stratification for cancers of breast, colon and prostate, but less so for others because of modest heritability and lower incidence.
Breast Cancer Association Consortium (BCAC)
Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON)
Colon Cancer Family Registry (CCFR)
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT)
Endometrial Cancer Association Consortium (ECAC)
Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)
Melanoma Genetics Consortium (GenoMEL)
Glioma International Case-Control Study (GICC)
International Lung Cancer Consortium (ILCCO)
Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium
International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph)
Ovarian Cancer Association Consortium (OCAC)
Oral Cancer GWAS
Pancreatic Cancer Case-Control Consortium (PanC4)
Pancreatic Cancer Cohort Consortium (PanScan)
Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)
Renal Cancer GWAS
Testicular Cancer Consortium (TECAC)
Genetic Predisposition to Disease
Polymorphism, Single Nucleotide
Genome-Wide Association Study
License start date
Nature communications, 2020, 11 (1), pp. 3353 - ?
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0
Showing items related by title, author, creator and subject.
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Schumacher, FR; Al Olama, AA; Berndt, SI; Benlloch, S; Ahmed, M; et al. (NATURE PORTFOLIO, 2018-07-01)Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data from a custom high-density array of 46,939 ...
Chen, H; Majumdar, A; Wang, L; Kar, S; Brown, KM; et al. (ELSEVIER, 2021-07-08)Genome-wide association studies (GWASs) have identified thousands of cancer risk loci revealing many risk regions shared across multiple cancers. Characterizing the cross-cancer shared genetic basis can increase our ...
Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Christensen, GB; Baffoe-Bonnie, AB; George, A; Powell, I; Bailey-Wilson, JE; et al. (WILEY-BLACKWELL, 2010-05-15)BACKGROUND: Prostate cancer (PC) is generally believed to have a strong inherited component, but the search for susceptibility genes has been hindered by the effects of genetic heterogeneity. The recently developed sumLINK ...